Masterclass in Cardiac Amyloidosis
Masterclass in Cardiac Amyloidosis:
Disease Spectrum, Diagnosis and Management
March 8-10, 2023
Registration is complimentary!
Join us March 8-10, 2024 for the virtual Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management.
Led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC, this program will focus on:
- the pathogenesis of cardiac amyloidosis;
- diagnostic techniques and pitfalls;
- management strategies;
- mechanisms to facilitate early diagnosis; and
- treatment and management.
Masterclass in Cardiac Amyloidosis will feature in-depth sessions led by expert cardiologists, multimodality imagers, hematologists, and neurologists to discuss the disease spectrum, diagnosis, and management of cardiac amyloidosis.
Credits
Earn up to 11* CME/MOC credits
Faculty

.png)
Learning Objectives
By the end of the program, you should be able to:
-
Describe amyloidosis, including specific types, cardiac features, and disease burden.
-
Identify barriers to identification and diagnosis of patients suspected of ATTR.
-
Summarize the diagnostic evaluation for cardiac amyloidosis including multimodality imaging and laboratory testing and identify prognostic markers.
-
Recognize patients at risk for hereditary ATTR (hATTR) and wild-type ATTR (wtATTR).
-
Explain the importance of genetic testing in hATTR.
-
Discuss the therapeutic landscape and impact on disease burden.
-
Define appropriate treatment and management strategies for patients with heart failure.
-
Formulate strategies for development of a multidisciplinary care team.
-
Evaluate potential community outreach activities to identify at-risk patients.
Agenda
Friday, March 8 |
||
Time (ET) |
Presentation |
Faculty |
5:00pm |
Introduction, Program Goals and Logistics |
Saurabh Malhotra, MD, MPH, FASNC |
5:05pm | ASNC's role in amyloidosis education | |
Session 1: Disease and Pathogenesis | Moderator: Saurabh Malhotra, MD, MPH, FASNC |
||
5:10pm |
Structure of amyloid fibrils and mechanism of organ deposition
|
Yvonne Eisele, PhD |
5:40pm |
Manifestation and early recognition of amyloidosis
|
David Wolinsky, MD, MASNC |
6:10pm |
Evaluation of polyneuropathy in amyloidosis
|
Sasha Zivkovic, MD, PhD |
6:40pm |
Prognostic markers in amyloidosis
|
Vaishali Sanchorawala, MD |
7:10pm |
Summary and closing comments |
Saurabh Malhotra, MD, MPH, FASNC |
Saturday, March 9 |
||
10:00am |
Introduction to Day 2 |
Saurabh Malhotra, MD, MPH, FASNC |
Session 2: Diagnostic Techniques and Pitfalls: A Case-Based Discussion | Moderator: David Wolinsky, MD, MASNC |
||
10:05am |
Routine and advanced echocardiography techniques
|
Matthew Parker, MD |
10:35am |
Cardiac magnetic resonance for diagnosis and disease management
|
Sarah Cuddy, MD |
11:05am |
Nuclear scintigraphy with bone avid tracers: Basics and beyond
|
Saurabh Malhotra, MD, MPH, FASNC |
11:35am |
Amyloid mutations and role of genetic testing
|
Ashutosh Wechalekar, MBBS, MD |
12:05pm |
Final comments |
Faculty |
Break |
||
Session 3: Management | Moderator: Saurabh Malhotra, MD, MPH, FASNC |
||
1:00pm |
Differentiating TTR from myeloma precursors
|
Ashutosh Wechalekar, MBBS, MD |
1:30pm |
Therapeutic landscape in ATTR: Approved and on the horizon
|
Prem Soman, MD, PhD, MASNC |
2:00pm |
Evaluation and management of cardiac rhythm disorders
|
Mazen Hanna, MD |
2:30pm |
Management of HF and supportive therapies
|
Ahmad Masri, MD |
3:00pm |
Closing comments |
Faculty |
3:15pm |
Adjourn |
|
Sunday, March 10 |
||
10:00am |
Introduction to Day 3 |
Saurabh Malhotra, MD, MPH, FASNC |
Session 4: Facilitating Diagnosis and Management of ATTR | Moderator: Saurabh Malhotra, MD, MPH, FASNC |
||
10:05am |
Role tissue diagnosis and challenges
|
Angela Dispenzieri, MD |
10:35am |
Community outreach and education
|
Isabelle Lousada |
11:05am |
Requisites for an amyloidosis center
|
Prem Soman, MD, PhD, MASNC |
11:35am |
Role of interdisciplinary care teams
|
Melissa Lyle, MD |
12:05pm |
Q&A |
|
Session 5: Challenging Case Studies in Amyloidosis | Moderator: Wael Jaber, MD |
||
1:00pm |
Red flag vs red herring |
Vasvi Singh, MD |
1:15pm |
Al or ATTR, that is the question |
Vaishali Sanchorawala, MD |
1:30pm |
PYP doesn’t fit. Must you acquit? |
Saurabh Malhotra, MD, MPH, FASNC |
1:45pm |
Novel amyloid tracers to the rescue |
Sharmila Dorbala, MD, MPH, MASNC |
2:00pm |
Gene positive, PYP negative, heart failure: To treat or not to treat |
Ahmad Masri, MD |
2:15pm |
Finding amyloidosis in a stack of polyneuropathies |
Sasha Zivkovic, MD |
2:30pm |
No amyloid under the microscope: Imaging and pathology discordance |
Angela Dispenzieri, MD |
2:45pm |
Q&A and closing comments |
Saurabh Malhotra, MD, MPH, FASNC |
*Credits subject to change.
This program is supported by an unrestricted educational grant from Pfizer, Inc.